Ztalmy Suspension
Product Images NDC 81583-100
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Ztalmy (NDC 81583-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Immedica Pharma Us Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Ztalmy 02)
Image (Ztalmy 03)
Image (Ztalmy 04)
Image (Ztalmy 05)
Image (Ztalmy 06)
Image (Ztalmy 07)
Image (Ztalmy 08)
Image (Ztalmy 09)
Image (Ztalmy 10)
Image (Ztalmy 11)
Image (Ztalmy 12)
Image (Ztalmy 13)
Principal Display Panel (50 mg/mL Bottle Label)
This is a description for an oral suspension medication called Ganaxolone, which is used for children and needs to be stored at a temperature of 15°C. The medication should be kept in a dry place, and the cap should remain closed. The recommended dosage is not given, and the reader is referred to the prescribing information from Marinus Pharmaceuticals, Inc. The medication should be administered using the provided syringe, and the shelf life is 30 days after the initial dose.*
Principal Display Panel (50 mg/mL Bottle Carton)
This appears to be a description of a medication called "Ganaxolone", which is an oral suspension with a concentration of 50 mg/mL. The text includes instructions for storage and administration, as well as a warning to read enclosed instructions before use. A pharmacist is also instructed to dispense a medication guide to each patient. No additional information is provided.*
Principal Display Panel (50 mg/mL Bottle Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.